Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models
Viviane M. Andrade(Inovio Pharmaceuticals (United States)), Trevor R.F. Smith(Inovio Pharmaceuticals (United States))
Cited by 10
Related Papers
The DNA-based Lassa vaccine INO-4500 confers durable protective efficacy in cynomolgus macaques against lethal Lassa fever
|Communications Medicine|2024|10